What are the benefits of taking eloralintide?

Research-grade eloralintide isn’t for anyone to take, so it has no established benefits for people. The data that exist come from Lilly’s clinical program. In a 48-week phase 2 trial of 263 adults with obesity or overweight, published in The Lancet, mean weight loss ranged from 9.5% at 1 mg to 20.1% at 9 mg, compared with 0.4% on placebo.

Those are results for an investigational drug under trial conditions, with nausea and fatigue rising at higher doses. Phase 3 ENLIGHTEN trials are now testing it in obesity, type 2 diabetes, sleep apnea and knee osteoarthritis. In the lab, it is a tool for studying amylin receptors and satiety. Read our research purposes only policy, then Shop eloralintide.

ELORALINTIDE 10MG
ELORALINTIDE 10MG